CarThera receives FDA approval for Phase 1/2a trial in glioblastoma
PDC*line Pharma obtains authorization to launch phase I/II trial of its cancer vaccine (PDC*lung01) in non-small cell lung cancer
SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath
Tetrahedron receives ‘Novel Food’ status for Ergoneine™, its unique-form L-ergothioneine
Minoryx receives approval from Spanish Agency to initiate phase 2 study in Friedreich’s Ataxia
Robocath obtains CE marking for R-One™, its robotic-assisted solution for treating coronary diseases
CarThera obtains ANSM approval to launch its Phase I-II clinical trial for the SonoCloud-9 device in the treatment of recurrent glioblastoma
Metafora biosystems receives reimbursement for test to help diagnose De Vivo disease
